CoChat
Sign Up
Cited by 15

The DOI matches its Crossref record.

Asthma and atopic dermatitis are associated with increased risk of clinical Plasmodium falciparum malaria

Herrant, Magali, Loucoubar, Cheikh, Bassène, Hubert, Gonçalves, Bronner, Boufkhed, Sabah, Diene Sarr, Fatoumata, Fontanet, Arnaud, Tall, Adama, Baril, Laurence, Mercereau-Puijalon, Odile, Mécheri, Salaheddine, Sakuntabhai, Anavaj, Paul, Richard·2013·BMJ Open
DOI 10.1136/bmjopen-2013-002835PMC PMC3731724
Open this paper in CoChat — free account

Abstract

Objectives: To assess the impact of atopy and allergy on the risk of clinical malaria. Design: A clinical and immunological allergy cross-sectional survey in a birth cohort of 175 children from 1 month to 14 years of age followed for up to 15 years in a longitudinal open cohort study of malaria in Senegal. Malaria incidence data were available for 143 of these children (aged 4 months to 14 years of age) for up to 15 years. Mixed-model regression analysis was used to determine the impact of allergy status on malaria incidence, adjusting for age, gender, sickle-cell trait and force of infection. Main outcome measures: Asthma, allergic rhinoconjunctivitis and atopic dermatitis status, the number of clinical Plasmodium falciparum malaria episodes since birth and associated parasite density. Results: 12% of the children were classified as asthmatic and 10% as having atopic dermatitis. These groups had respectively a twofold (OR 2.12 95%; CI 1.46 to 3.08; p=8×10 −5 ) and threefold (OR 3.15; 1.56 to 6.33; p=1.3×10 −3 ) increase in the risk of clinical P falciparum malaria once older than the age of peak incidence of clinical malaria (3–4 years of age). They also presented with higher P falciparum parasite densities (asthma: mean 105.3 parasites/μL±SE 41.0 vs 51.3±9.7; p=6.2×10 −3 . Atopic dermatitis: 135.4±70.7 vs 52.3±11.0; p=0.014). There was no effect of allergy on the number of non-malaria clinical presentations. Individuals with allergic rhinoconjunctivitis did not have an increased risk of clinical malaria nor any difference in parasite densities. Conclusions: These results demonstrate that asthma and atopic dermatitis delay the development of clinical immunity to P falciparum . Despite the encouraging decrease in malaria incidence rates in Africa, a significant concern is the extent to which the increase in allergy will exacerbate the burden of malaria. Given the demonstrated antiparasitic effect of antihistamines, administration to atopic children will likely reduce the burden of clinical malaria in these children, increase the efficacy of first-line treatment antimalarials and alleviate the non-infectious consequences of atopy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2013-002835

Cites

Statistics

Figures

Figure 1 Annual incidence rate of clinical Plasmodium falciparum episodes per 100 children (bold line). In order to overcome the fluctuations of the annual incidence rate, we fit second (dotted line), third (dashed line) and fourth (solid line) degree polynomial trend lines to the data (bold line). The corresponding R2 values are 0.70, 0.91 and 0.99, respectively, indicating an accurate fit for third and fourth order polynomials. The inflexion on these two trend lines indicates the onset of acquisition of clinical immunity at approximately 3–4 years of age.
Figure 1 Annual incidence rate of clinical Plasmodium falciparum episodes per 100 children (bold line). In order to overcome the fluctuations of the annual incidence rate, we fit second (dotted line), third (dashed line) and fourth (solid line) degree polynomial trend lines to the data (bold line). The corresponding R2 values are 0.70, 0.91 and 0.99, respectively, indicating an accurate fit for third and fourth order polynomials. The inflexion on these two trend lines indicates the onset of acquisition of clinical immunity at approximately 3–4 years of age.CC BY-NC · PubMed Central
Figure 2 Mean cumulative number of Plasmodium falciparum clinical episodes with age for the (A) asthma, (B) rhinoconjunctivitis and (C) atopic dermatitis classes and overall atopy class (D) (bold lines) compared with individuals without symptoms of each respective allergy type (thin lines). In all cases moderate and severe classes are combined and compared with individuals without allergy symptoms. Note there are no children older than 11 years of age with atopic dermatitis.
Figure 2 Mean cumulative number of Plasmodium falciparum clinical episodes with age for the (A) asthma, (B) rhinoconjunctivitis and (C) atopic dermatitis classes and overall atopy class (D) (bold lines) compared with individuals without symptoms of each respective allergy type (thin lines). In all cases moderate and severe classes are combined and compared with individuals without allergy symptoms. Note there are no children older than 11 years of age with atopic dermatitis.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 48

  1. 10.1016/S0140-6736(06)69283-0 · DOI · Paper page
  2. 10.1146/annurev.iy.07.040189.001045 · DOI · Paper page
  3. 10.1182/blood-2008-05-078154 · DOI
  4. 10.1046/j.1365-2249.1997.4401337.x · DOI
  5. 10.1016/S0165-2478(98)00120-5 · DOI
  6. 10.1186/1475-2875-8-286 · DOI
  7. 10.1038/192733a0 · DOI
  8. Perlmann, 1994, IgE elevation and IgE anti-malarial antibodies in Plasmodium falciparum malaria:association of high IgE levels with cerebral malaria, Clin Exp Immunol, 97, 284, 10.1111/j.1365-2249.1994.tb06082.x · DOI
  9. 10.1186/1475-2875-6-1 · DOI
  10. 10.1016/S0140-6736(98)10321-5 · DOI
  11. 10.1164/rccm.200406-730OC · DOI
  12. 10.1016/S0140-6736(96)91617-7 · DOI
  13. 10.1038/425576a · DOI
  14. 10.1126/science.275.5296.77 · DOI
  15. Gould, 2007, The allergic march from Staphylococcus aureus superantigens to immunoglobulin E, Chem Immunol Allergy, 93, 106, 10.1159/000100861 · DOI
  16. 10.1038/sj.gene.6364169 · DOI
  17. 10.1016/j.jaci.2006.04.036 · DOI
  18. Zhang, 2003, Positional cloning of a quantitative trait locus on chromosome 13q14 that influences immunoglobulin E levels and asthma, Nat Genet, 34, 181, 10.1038/ng1166 · DOI
  19. 10.1371/journal.pone.0002000 · DOI
  20. 10.1086/511051 · DOI · Paper page
  21. 10.1016/j.jaci.2004.10.024 · DOI
  22. 10.1007/s002510000286 · DOI
  23. 10.1084/jem.20071548 · DOI
  24. 10.1016/0035-9203(76)90004-3 · DOI
  25. Bhattacharya, 1988, Histamine & kinin system in experimental malaria, Indian J Med Res, 88, 558
  26. 10.1016/S1473-3099(11)70194-3 · DOI
  27. 10.1038/ng786 · DOI
  28. 10.1183/09031936.95.08030483 · DOI · Paper page
  29. Yamada, 2002, International Study of Asthma and Allergies in Childhood (ISAAC): validation of the written questionnaire (eczema component) and prevalence of atopic eczema among Brazilian children, J Investig Allergol Clin Immunol, 12, 34
  30. 10.1016/S1471-4922(01)02117-1 · DOI
  31. 10.1126/science.296.5567.490 · DOI
  32. 10.1128/IAI.06414-11 · DOI
  33. Machado A Loucoubar C Grange L . Human genetic contribution to the outcome of infection with malaria parasites. In: Okwa O . ed. Malaria parasites, Rijeka: INTECH, 2012:267–292. · DOI
  34. 10.1128/CMR.00025-08 · DOI
  35. 10.1098/rstb.1997.0124 · DOI
  36. 10.1590/S0074-02761994000600013 · DOI
  37. Lell, 2001, Atopy and malaria, Wien Klin Wochenschr, 113, 927
  38. 10.1046/j.1365-2222.2003.01540.x · DOI
  39. 10.4049/jimmunol.168.4.1704 · DOI
  40. 10.1080/00034989859366 · DOI
  41. Mecheri, 2011, Contribution of allergic inflammatory response to the pathogenesis of malaria disease, Biochim Biophys Acta, 1822, 49, 10.1016/j.bbadis.2011.02.005 · DOI
  42. Sowunmi, 2007, Enhancement of the antimalarial efficacy of amodiaquine by chlorpheniramine in vivo, Mem Inst Oswaldo Cruz, 102, 417, 10.1590/S0074-02762007005000038 · DOI
  43. 10.1038/nchembio806 · DOI
  44. 10.1073/pnas.201191498 · DOI
  45. De Silva PM Marshall JM . Factors contributing to urban malaria transmission in sub-Saharan Africa: a systematic review. J Trop Med 2012:819563. doi: 10.1155/2012/819563 · DOI · Paper page
  46. Bob, 2010, Parasite polymorphism and severe malaria in Dakar (Senegal): a West African urban area, PLoS ONE, 5, e9817, 10.1371/journal.pone.0009817 · DOI
  47. Musonda, 2009, Chloroquine-astemizole hybrids with potent in vitro and in vivo antiplasmodial activity, Bioorg Med Chem Lett, 19, 481, 10.1016/j.bmcl.2008.11.047 · DOI
  48. 10.1097/QCO.0b013e3282f1673a · DOI

Cited by

Sorted by citations

Metadata

Authors
Herrant, M., Loucoubar, C., Bassène, H., Gonçalves, B., Boufkhed, S., Diene Sarr, F., Fontanet, A., Tall, A., Baril, L., Mercereau-Puijalon, O., Mécheri, S., Sakuntabhai, A., & Paul, R.
Venue
BMJ Open
Publisher
BMJ
Published
2013-07
Volume
3
Issue
7
Pages
e002835
ISSN
2044-6055
DOI
10.1136/bmjopen-2013-002835
PMC
PMC3731724
Cited by
15
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review